Literature DB >> 29869391

In Reference to Trends, Etiologies, and Predictors of 90-Day Readmission After Percutaneous Ventricular Assist Device Implantation: A National Population-Based Cohort Study.

James J Glazier1, Amir Kaki1.   

Abstract

Mesh：

Year:  2018        PMID： 29869391      PMCID： PMC6489835          DOI： 10.1002/clc.22989

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN： 0160-9289            Impact factor:   2.882


× No keyword cloud information.
  5 in total

Review 1.  Impella ventricular support in clinical practice: Collaborative viewpoint from a European expert user group.

Authors:  Francesco Burzotta; Carlo Trani; Sagar N Doshi; Jonathan Townend; Robert Jan van Geuns; Patrick Hunziker; Bernhard Schieffer; Konstantinos Karatolios; Jacob Eifer Møller; Flavio L Ribichini; Andreas Schäfer; José P S Henriques
Journal:  Int J Cardiol       Date:  2015-07-30       Impact factor: 4.164

2.  The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience.

Authors:  Annemarie E Engström; Ricardo Cocchieri; Antoine H Driessen; Krischan D Sjauw; Marije M Vis; Jan Baan; Mark de Jong; Wim K Lagrand; Jos A P van der Sloot; Jan G Tijssen; Robbert J de Winter; Bas A S de Mol; Jan J Piek; José P J M Henriques
Journal:  Crit Care Med       Date:  2011-09       Impact factor: 7.598

3.  2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention.

Authors:  Charanjit S Rihal; Srihari S Naidu; Michael M Givertz; Wilson Y Szeto; James A Burke; Navin K Kapur; Morton Kern; Kirk N Garratt; James A Goldstein; Vivian Dimas; Thomas Tu
Journal:  J Am Coll Cardiol       Date:  2015-04-07       Impact factor: 24.094

4.  Improved survival rates support left ventricular assist device implantation early after myocardial infarction.

Authors:  J M Chen; J J DeRose; J P Slater; T B Spanier; T M Dewey; K A Catanese; M A Flannery; M C Oz
Journal:  J Am Coll Cardiol       Date:  1999-06       Impact factor: 24.094

5.  Trends, etiologies, and predictors of 90-day readmission after percutaneous ventricular assist device implantation: A national population-based cohort study.

Authors:  Hafeez Ul Hassan Virk; Byomesh Tripathi; Shuchita Gupta; Akanksha Agrawal; Sandeep Dayanand; Faisal Inayat; Chayakrit Krittanawong; Ali Raza Ghani; Mohammad Nour Zabad; Parasuram Melarcode Krishnamoorthy; Aman Amanullah; Gregg Pressman; Christian Witzke; Sean Janzer; Jon George; Sanjog Kalra; Vincent Figueredo
Journal:  Clin Cardiol       Date:  2018-05-10       Impact factor: 2.882
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.